MktsMarkets

MediciNova, Inc.
NASDAQ: MNOVKey statistics
MNOV News
Stories mentioning MNOV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 187.00 | 123.00 | 135.00 | |||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Operating Expenses | ||||||||
| Research & Development | 1,200 | 1,500 | 1,500 | 2,000 | 1,700 | 1,800 | 1,800 | 1,500 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,023 | 3,244 | 3,504 | 3,742 | 3,203 | 3,184 | 3,309 | 3,046 |
| Operating Income (Loss) | (2,836) | (3,092) | (3,381) | (3,607) | (3,203) | (3,184) | (3,309) | (3,046) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (3.00) | (6.00) | (10.00) | 1.00 | 2.00 | (15.00) | 9.00 | (17.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,586) | (2,803) | (3,050) | (3,281) | (2,864) | (2,815) | (2,852) | (2,628) |
| Earnings Per Share (Basic) | (0.05) | (0.06) | (0.06) | (0.07) | (0.06) | (0.06) | (0.06) | (0.05) |
| Earnings Per Share (Diluted) | (0.05) | (0.06) | (0.06) | (0.07) | (0.06) | (0.06) | (0.06) | (0.05) |
| Weighted Average Shares Outstanding (Basic) | 49,221 | 49,063 | 49,046 | 49,046 | 49,046 | 49,046 | 49,046 | 49,046 |
| Weighted Average Shares Outstanding (Diluted) | 49,221 | 49,063 | 49,046 | 49,046 | 49,046 | 49,046 | 49,046 | 49,046 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MNOV
MediciNova, Inc. (NASDAQ: MNOV) is a stock listed on the Nasdaq Stock Market under the ticker symbol MNOV. It last traded at $1.33 (Nov 18, 2026, 9:30 AM ET), down 0.8% on the day. That gives MediciNova a market capitalisation of $69.4M.
Over the past 52 weeks MNOV has traded between $1.22 and $3.90.
Revenue for the quarter ended Mar 31, 2026 was $187.0K; a net loss of $2.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $187.0K | -$2.6M | -1382.9% |
| Dec 31, 2025 | — | -$2.8M | — |
| Sep 30, 2025 | $123.0K | -$3.1M | -2479.7% |
| Jun 30, 2025 | $135.0K | -$3.3M | -2430.4% |
From MediciNova’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…